Hoth Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	9.29	6.43	8.54	2.63	1.89	0.28
Short-Term Investments	0	0.21	1.94	2.06	0.8	0
Cash & Cash Equivalents	9.29	6.64	10.48	4.69	2.69	0.28
Cash Growth	39.99%	-36.67%	123.34%	74.16%	853.41%	-
Other Current Assets	0.14	0.09	0.09	0.09	-0.06	0.22
Total Current Assets	9.43	6.73	10.58	4.78	2.64	0.5
Property, Plant & Equipment	0.06	0	0	0	0	0
Long-Term Investments	0.04	0.03	0.41	0.46	0	0
Other Long-Term Assets	0	0	0	0	0.2	0
Total Long-Term Assets	0.09	0.03	0.41	0.46	0.2	0
Total Assets	9.52	6.76	10.99	5.24	2.84	0.5
Accounts Payable	0.04	0.69	0.36	0.13	0.4	0.14
Current Debt	0.03	0	0	0	0	0
Other Current Liabilities	0.61	0.69	0.51	0.18	0.04	0.21
Total Current Liabilities	0.68	1.39	0.87	0.31	0.44	0.35
Long-Term Debt	0.03	0	0	0	0	0
Other Long-Term Liabilities	0	0.25	0.24	0.29	0	0
Total Long-Term Liabilities	0.03	0.25	0.24	0.29	0	0
Total Liabilities	0.7	1.64	1.1	0.6	0.44	0.35
Total Debt	0.06	0	0	0	0	0
Retained Earnings	-52.94	-45.1	-33.73	-19.41	-12.22	-4.51
Comprehensive Income	0.03	0.02	0.02	-0.02	0	0
Shareholders' Equity	8.82	5.12	9.88	4.65	2.4	0.15
Net Cash / Debt	9.24	6.64	10.48	4.69	2.69	0.28
Net Cash / Debt Growth	39.16%	-36.67%	123.34%	74.16%	853.41%	-
Net Cash Per Share	2.71	5.54	11.73	9.49	7.35	1.40
Working Capital	8.75	5.34	9.71	4.47	2.19	0.15
Book Value Per Share	2.59	4.28	11.06	9.39	6.54	0.77

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).